TraceGains Explains Implications for FDA Recently Released Operational Strategy for FSMA
On May 2, 2014, the FDA released their Operational Strategy for FSMA implementation. The strategy is composed of three main elements or themes: advancing public health, leveraging and collaborating, and strategic and risk-based industry oversight. Jennifer Brusco, TraceGains’ Marketing Specialist, explores what this entails in the current company blog.
View full press release